Lutetium [177Lu] BL-ARC001

DRUG2 trials

Sponsors

Sichuan Baili Pharmaceutical Co., Ltd.

Conditions

Breast CancerGastrointestinal TumorsHead and Neck Squamous Cell CarcinomaLung CancerSolid Tumors

Phase 1

A Study of Lutetium [177Lu] BL-ARC001 in Patients With Locally Advanced or Metastatic Gastrointestinal Tumors and Other Solid Tumors

RecruitingNCT07232407

Sichuan Baili Pharmaceutical Co., Ltd.Gastrointestinal Tumors, Solid Tumors

Start: 2025-11-14End: 2027-12-31Target: 22Updated: 2026-01-07

A Study of Lutetium [177Lu]-BL-ARC001 in Patients With Locally Advanced or Metastatic Lung Cancer, Breast Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors

RecruitingNCT07274852

Sichuan Baili Pharmaceutical Co., Ltd.Breast Cancer, Head and Neck Squamous Cell Carcinoma, Lung Cancer +1

Start: 2025-12-10End: 2027-12-31Target: 22Updated: 2026-01-06